Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced the voting results from its Annual Meeting of Shareholders held on Monday June 8th, 2015.
Canaccord Genuity analyst Neil Maruoka came out with his views on Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), after the company provided updated guidance on its planned registration …
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that all nominees listed in the management information circular dated May 6, 2015 were elected as directors at …
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) provided an update on its planned registration program for REOLYSIN®, its proprietary formulation of the human reovirus, at its Annual …
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that following submission to the U.
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, announced that the European …
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that it has received a letter from the NASDAQ OMX Group (“Nasdaq”) determining that the Company is …
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) today announced that a series of poster presentations by the Company’s research collaborators will be made at the …
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that …
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that Dr.
